MedSci Healthcare Holdings (HKSE:02415) EBITDA Margin % : 26.31% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is MedSci Healthcare Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. MedSci Healthcare Holdings's EBITDA for the six months ended in Dec. 2023 was HK$56.9 Mil. MedSci Healthcare Holdings's Revenue for the six months ended in Dec. 2023 was HK$216.3 Mil. Therefore, MedSci Healthcare Holdings's EBITDA margin for the quarter that ended in Dec. 2023 was 26.31%.

MedSci Healthcare Holdings EBITDA Margin % Historical Data

The historical data trend for MedSci Healthcare Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedSci Healthcare Holdings EBITDA Margin % Chart

MedSci Healthcare Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

18.85

-46.45

-25.09

19.78

MedSci Healthcare Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial			-	-76.08	7.20	11.25	26.31

Competitive Comparison of MedSci Healthcare Holdings's EBITDA Margin %

For the Health Information Services subindustry, MedSci Healthcare Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedSci Healthcare Holdings's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedSci Healthcare Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where MedSci Healthcare Holdings's EBITDA Margin % falls into.

MedSci Healthcare Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

MedSci Healthcare Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	75.554	/	381.941
	=	19.78 %

MedSci Healthcare Holdings's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	56.924	/	216.343
	=	26.31 %

MedSci Healthcare Holdings (HKSE:02415) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

MedSci Healthcare Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of MedSci Healthcare Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

MedSci Healthcare Holdings (HKSE:02415) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedSci Healthcare Holdings Ltd (HKSE:02415) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 258, Xinzhuan Road, 18th Floor, Building 34, Songjiang District, Shanghai, CHN

Website

https://ir.medsci.cn

MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the Company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.

Executives

Li Xinmei	2202 Interest of your spouse
Zhang Fabao	2201 Interest of corporation controlled by you
Dtx Health Limited	2101 Beneficial owner
Yu Jia	2201 Interest of corporation controlled by you
Dragon Step Ventures Limited	2101 Beneficial owner
Shanghai Qichang Investment Consulting Co., Ltd.	2201 Interest of corporation controlled by you
Suzhou Qicheng Investment Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Suzhou Qiming Ronghe Venture Capital Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Image Frame Investment (hk) Limited
Tencent Holdings Limited
Microhealth Limited	2101 Beneficial owner
Hu Xubo	2201 Interest of corporation controlled by you
Meiyue Limited	2101 Beneficial owner

MedSci Healthcare Holdings (HKSE:02415) Headlines

No Headlines